Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Oncology Letters
|
December 19, 2013
Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Clinical Journal of Gastroenterology
|
April 17, 2022
Usefulness of partial splenic embolization for left-sided portal hypertension in a patient with a pancreatic neuroendocrine neoplasm: a case report and review of the literature
Teppei Matsui, Hidenari Nagai, Makoto Amanuma, et al.
Clinical Cancer Drugs
|
September 6, 2016
The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy
Koichi Momiyama, Hidenari Nagai, Yu Ogino, et al.
Case Reports in Oncology
|
December 19, 2014
Delayed intratumoral hemorrhage after drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Hepato-Gastroenterology
|
July 10, 2015
Comparison of Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Cancer Chemotherapy and Pharmacology
|
February 25, 2010
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma
Hidenari Nagai, Teppei Matsui, Masahiro Kanayama, et al.
Hepato-Gastroenterology
|
July 16, 2015
Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients
Hidenari Nagai, Takanori Mukouzu, Daigo Matsui, et al.
Cancer Chemotherapy and Pharmacology
|
November 14, 2013
Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib
Hidenari Nagai, Takenori Kanekawa, Kojiro Kobayashi, et al.
Anticancer Research
|
February 27, 2026
Clinical Utility of Tremelimumab/Durvalumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: Serum Cytokine Profile Insights
Kunihide Mohri, Hidenari Nagai, Takanori Mukozu, et al.
Oncology
|
September 12, 2024
The Usefulness of Serum Interleukin-6 as a Predictor of Response to Atezolizumab plus Bevacizumab Combination Treatment in Hepatocellular Carcinoma
Takanori Mukozu, Hidenari Nagai, Hideki Nagumo, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Oncology Letters
|
December 19, 2013
Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Clinical Journal of Gastroenterology
|
April 17, 2022
Usefulness of partial splenic embolization for left-sided portal hypertension in a patient with a pancreatic neuroendocrine neoplasm: a case report and review of the literature
Teppei Matsui, Hidenari Nagai, Makoto Amanuma, et al.
Clinical Cancer Drugs
|
September 6, 2016
The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy
Koichi Momiyama, Hidenari Nagai, Yu Ogino, et al.
Case Reports in Oncology
|
December 19, 2014
Delayed intratumoral hemorrhage after drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Hepato-Gastroenterology
|
July 10, 2015
Comparison of Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Cancer Chemotherapy and Pharmacology
|
February 25, 2010
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma
Hidenari Nagai, Teppei Matsui, Masahiro Kanayama, et al.
Hepato-Gastroenterology
|
July 16, 2015
Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients
Hidenari Nagai, Takanori Mukouzu, Daigo Matsui, et al.
Cancer Chemotherapy and Pharmacology
|
November 14, 2013
Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib
Hidenari Nagai, Takenori Kanekawa, Kojiro Kobayashi, et al.
Anticancer Research
|
February 27, 2026
Clinical Utility of Tremelimumab/Durvalumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: Serum Cytokine Profile Insights
Kunihide Mohri, Hidenari Nagai, Takanori Mukozu, et al.
Oncology
|
September 12, 2024
The Usefulness of Serum Interleukin-6 as a Predictor of Response to Atezolizumab plus Bevacizumab Combination Treatment in Hepatocellular Carcinoma
Takanori Mukozu, Hidenari Nagai, Hideki Nagumo, et al.
Page
of 7